The significance of ANCA positivity in patients with inflammatory bowel disease
- 1 October 2019
- Vol. 51 (6) , 634-639
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Contribution of immunofluorescence to identification and characterization of antineutrophil cytoplasmic antibodies in inflammatory bowel diseaseIndian Journal of Gastroenterology, 2011
- Diagnostic Role and Clinical Association of ASCA and ANCA in Brazilian Patients with Inflammatory Bowel DiseaseDigestive Diseases and Sciences, 2009
- Serologic Markers in Inflammatory Bowel DiseaseClinical Chemistry, 2006
- Diagnostic role and clinical correlates of anti-Saccharomyces cerevisiae antibodies (ASCA) and anti-neutrophil cytoplasmic antibodies (p-ANCA) in Italian patients with inflammatory bowel diseasesDigestive and Liver Disease, 2003
- Differentiation of antineutrophil nuclear antibodies in inflammatory bowel and autoimmune liver diseases from antineutrophil cytoplasmic antibodies (p-ANCA) using immunofluorescence microscopyClinical and Experimental Immunology, 2001
- Are anti-neutrophil cytoplasmic antibodies (ANCA) clinically useful in inflammatory bowel disease (IBD)?Clinical and Experimental Immunology, 1999
- International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA)American Journal of Clinical Pathology, 1999
- Anti-Neutrophil Cytoplasmic Antibodies in Chronic Inflammatory Bowel Disease: Prevalence and Diagnostic RoleScandinavian Journal of Gastroenterology, 1995
- Anti-Neutrophil Cytoplasmic Autoantibodies with Specificity for Myeloperoxidase in Patients with Systemic Vasculitis and Idiopathic Necrotizing and Crescentic GlomerulonephritisNew England Journal of Medicine, 1988
- AUTOANTIBODIES AGAINST NEUTROPHILS AND MONOCYTES: TOOL FOR DIAGNOSIS AND MARKER OF DISEASE ACTIVITY IN WEGENER'S GRANULOMATOSISThe Lancet, 1985